Blogs, Rare diseases

Six steps for a successful Early Access Program in Europe 

News

Sciensus achieves prestigious National Equality Standard (NES) accreditation

Thought Leadership, Cancer

Investigating patient benefits in home cancer treatment

Thought Leadership, Rare diseases

Get the free whitepaper: Transitioning from open-label extensions to early access programs

News

Our patients speak: 2024 patient satisfaction survey results

News

Sciensus achieves ISO certification for best practices in the processing of personal data

Blogs, Cancer

Highlights from the ESMO 2024 conference

News

Sciensus names Christian Tucat as Chief Executive Officer

Thought Leadership

Beyond adherence driving future healthcare through patient support programmes